ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 313

$1.22M Total Retail Price of All Prescriptions

Rank: 8 out of 313

665 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 3,036 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$124 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
TRAZODONE HCL 641 208 1 1
RISPERIDONE 410 110 2 2
ZOLPIDEM TARTRATE 381 106 3 8
LAMOTRIGINE 370 110 4 9
CYMBALTA 357 172 5 10
CITALOPRAM HBR 351 170 6 5
QUETIAPINE FUMARATE 338 94 7 4
BENZTROPINE MESYLATE 332 26 R 8 3
VENLAFAXINE HCL ER 331 106 9 13
FLUOXETINE HCL 293 92 10 7
ABILIFY 291 53 11 12
MIRTAZAPINE 259 148 12 15
DIVALPROEX SODIUM ER 238 40 13 14
OLANZAPINE 230 78 14 11
BUSPIRONE HCL 215 90 15 27
SERTRALINE HCL 209 56 16 6
GABAPENTIN 203 66 17 22
BUPROPION XL 192 79 18 17
SEROQUEL 167 48 19 18
ESCITALOPRAM OXALATE 165 77 20 21
LITHIUM CARBONATE 165 35 20 24
SEROQUEL XR 161 55 22 31
PAROXETINE HCL 156 58 23 16
TOPIRAMATE 138 38 24 30
DONEPEZIL HCL 138 80 24 32
HALOPERIDOL 128 18 26 23
ZIPRASIDONE HCL 117 0 27 20
NAMENDA 98 61 28 29
HYDROXYZINE PAMOATE 98 38 R 28 25
PRISTIQ ER 82 16 30 48
THIORIDAZINE HCL 82 11 R 30 94
BUPROPION HCL SR 81 30 32 19
LEVETIRACETAM 78 12 33 60
INVEGA 76 0 34 43
DIVALPROEX SODIUM 74 0 35 26
CLONAZEPAM 74 35 35 50
AMPHETAMINE SALT COMBO 72 12 S2 37 33
NUEDEXTA 71 18 38 133
CARBAMAZEPINE 70 0 39 47
PROPRANOLOL HCL 70 17 39 51
LUNESTA 61 18 41 66
GEODON 60 15 42 46
LEXAPRO 60 30 42 57
DOXEPIN HCL 59 25 44 40
CLOZAPINE 57 0 45 28
VENLAFAXINE HCL 55 20 46 49
BUPROPION HCL 55 22 46 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.